Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?

Objective Obesity is associated with elevated C reactive protein (CRP) levels. The Ankylosing Spondylitis Disease Activity Score (ASDAS) combines patient-reported outcomes (PROs) and CRP. We evaluated the effect of body mass index (BMI) on CRP and on ASDAS, and studied if ASDAS can be used in obese...

Full description

Saved in:
Bibliographic Details
Main Authors: Robert Landewé, Désirée van der Heijde, Hanne Dagfinrud, Roberta Ramonda, Floris A van Gaalen, Rosaline van den Berg, Pauline A C Bakker, Zineb Ez-Zaitouni, Miranda van Lunteren, Esmeralda Molenaar, Roxana Rubio Vargas
Format: Article
Language:English
Published: BMJ Publishing Group 2016-06-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/2/1/e000283.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849762338059583488
author Robert Landewé
Désirée van der Heijde
Hanne Dagfinrud
Roberta Ramonda
Floris A van Gaalen
Rosaline van den Berg
Pauline A C Bakker
Zineb Ez-Zaitouni
Miranda van Lunteren
Esmeralda Molenaar
Roxana Rubio Vargas
author_facet Robert Landewé
Désirée van der Heijde
Hanne Dagfinrud
Roberta Ramonda
Floris A van Gaalen
Rosaline van den Berg
Pauline A C Bakker
Zineb Ez-Zaitouni
Miranda van Lunteren
Esmeralda Molenaar
Roxana Rubio Vargas
author_sort Robert Landewé
collection DOAJ
description Objective Obesity is associated with elevated C reactive protein (CRP) levels. The Ankylosing Spondylitis Disease Activity Score (ASDAS) combines patient-reported outcomes (PROs) and CRP. We evaluated the effect of body mass index (BMI) on CRP and on ASDAS, and studied if ASDAS can be used in obese axial spondyloarthritis (axSpA) patients to assess disease activity.Methods Baseline data of patients with chronic back pain of short duration included in the SPondyloArthritis Caught Early (SPACE) cohort were used. Collected data included BMI and ASDAS. Patients were classified according to the ASAS axSpA classification criteria and BMI (overweight ≥25 and obese ≥30). Correlation and linear regression analyses were performed to assess the relation between BMI and ASDAS. Linear regression models were performed to assess if age or gender were effect modifiers in the relation between BMI and CRP, and between BMI and ASDAS.Results In total, 428 patients were analysed (n=168 axSpA; n=260 no-axSpA). The mean age was 31.1 years, 36.9% were male, 26.4% were overweight and 13.3% obese, median CRP was 3 mg/L and the mean ASDAS was 2.6. Gender was the only factor modifying the relationship between BMI and CRP as BMI had an influence on CRP only in females (β=0.35; p<0.001). Correlations between BMI and CRP or PROs were generally weak, and only significant for CRP in female patients. BMI was not related to ASDAS in axSpA patients.Conclusions ASDAS is not affected by BMI in axSpA patients. Therefore, based on our data it is not necessary to take BMI in consideration when assessing disease activity using ASDAS in axSpA patients.
format Article
id doaj-art-add3bbe1ae5f40ed95bc1e514b0bae3a
institution DOAJ
issn 2056-5933
language English
publishDate 2016-06-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj-art-add3bbe1ae5f40ed95bc1e514b0bae3a2025-08-20T03:05:45ZengBMJ Publishing GroupRMD Open2056-59332016-06-012110.1136/rmdopen-2016-000283Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?Robert Landewé0Désirée van der Heijde1Hanne Dagfinrud2Roberta Ramonda3Floris A van Gaalen4Rosaline van den Berg5Pauline A C Bakker6Zineb Ez-Zaitouni7Miranda van Lunteren8Esmeralda Molenaar9Roxana Rubio Vargas10Rheumatology, Zuyderland Medical Centre, Sittard-Geleen, The Netherlands1 Department of Rheumatology, Leiden University Medical Center, Leiden, The NetherlandsInstitute of Health and Society, Faculty of Medicine, University of Oslo, Oslo, NorwayRheumatology Unit, Padua University Hospital, Padova, Veneto, ItalyRheumatology, Leiden University Medical Center, Leiden, Zuid-Holland, Netherlands1Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands1Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands1Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands7 Rheumatology, Leiden University Medical Center, Leiden, The NetherlandsDepartment of Rheumatology, Groene Hart Hospital, Gouda, The Netherlands1Department of Rheumatology, Leiden University Medical Center, Leiden, The NetherlandsObjective Obesity is associated with elevated C reactive protein (CRP) levels. The Ankylosing Spondylitis Disease Activity Score (ASDAS) combines patient-reported outcomes (PROs) and CRP. We evaluated the effect of body mass index (BMI) on CRP and on ASDAS, and studied if ASDAS can be used in obese axial spondyloarthritis (axSpA) patients to assess disease activity.Methods Baseline data of patients with chronic back pain of short duration included in the SPondyloArthritis Caught Early (SPACE) cohort were used. Collected data included BMI and ASDAS. Patients were classified according to the ASAS axSpA classification criteria and BMI (overweight ≥25 and obese ≥30). Correlation and linear regression analyses were performed to assess the relation between BMI and ASDAS. Linear regression models were performed to assess if age or gender were effect modifiers in the relation between BMI and CRP, and between BMI and ASDAS.Results In total, 428 patients were analysed (n=168 axSpA; n=260 no-axSpA). The mean age was 31.1 years, 36.9% were male, 26.4% were overweight and 13.3% obese, median CRP was 3 mg/L and the mean ASDAS was 2.6. Gender was the only factor modifying the relationship between BMI and CRP as BMI had an influence on CRP only in females (β=0.35; p<0.001). Correlations between BMI and CRP or PROs were generally weak, and only significant for CRP in female patients. BMI was not related to ASDAS in axSpA patients.Conclusions ASDAS is not affected by BMI in axSpA patients. Therefore, based on our data it is not necessary to take BMI in consideration when assessing disease activity using ASDAS in axSpA patients.https://rmdopen.bmj.com/content/2/1/e000283.full
spellingShingle Robert Landewé
Désirée van der Heijde
Hanne Dagfinrud
Roberta Ramonda
Floris A van Gaalen
Rosaline van den Berg
Pauline A C Bakker
Zineb Ez-Zaitouni
Miranda van Lunteren
Esmeralda Molenaar
Roxana Rubio Vargas
Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?
RMD Open
title Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?
title_full Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?
title_fullStr Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?
title_full_unstemmed Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?
title_short Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?
title_sort does body mass index bmi influence the ankylosing spondylitis disease activity score in axial spondyloarthritis
url https://rmdopen.bmj.com/content/2/1/e000283.full
work_keys_str_mv AT robertlandewe doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT desireevanderheijde doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT hannedagfinrud doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT robertaramonda doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT florisavangaalen doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT rosalinevandenberg doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT paulineacbakker doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT zinebezzaitouni doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT mirandavanlunteren doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT esmeraldamolenaar doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis
AT roxanarubiovargas doesbodymassindexbmiinfluencetheankylosingspondylitisdiseaseactivityscoreinaxialspondyloarthritis